Form 4: ClearPoint Neuro Director Exercises Restricted Stock Units
SEC Form 4 Filing
Pascal E. R. Girin, a director of ClearPoint Neuro, Inc., converted 17,153 restricted stock units into common stock on May 14, 2024.
Summary
- On May 14, 2024, Pascal E. R. Girin, a director of ClearPoint Neuro, Inc. (CLPT), converted 17,153 restricted stock units into common stock.
- This transaction increased Girin's direct holdings to 72,197 shares of common stock.
- The restricted stock units were granted on May 25, 2023, and vested on the earlier of the first anniversary of the grant date or the day immediately preceding the company's 2024 annual meeting of stockholders.
Sentiment
Score: 5
Explanation: This Form 4 filing is a neutral event, simply reflecting a director's exercise of previously granted stock units. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a standard Form 4 filing, indicating a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors.
Stakeholder Impact
- The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| May 25, 2023 | Date the reporting person was granted 17,153 restricted stock units. |
| May 14, 2024 | Date of transaction where restricted stock units were converted into common stock. |
| May 15, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.